Multi-drug resistance (MDR) is a significant challenge in biopharmaceutics, where certain diseases exhibit resistance to multiple medications. This phenomenon often arises in the treatment of cancers and infectious diseases, limiting the effectiveness of therapeutic interventions.
In biopharmaceutics research, combating MDR involves exploring innovative drug delivery systems and formulations that can overcome resistance mechanisms. Nanotechnology, for instance, offers promising solutions by enabling targeted drug delivery, minimizing side effects, and enhancing drug efficacy against resistant strains.
Understanding the molecular basis of MDR is crucial for designing biopharmaceuticals that can bypass or inhibit resistance mechanisms. This knowledge paves the way for the development of next-generation drugs capable of overcoming the challenges posed by multi-drug resistance, thereby improving treatment outcomes and patient care.
Submit your abstract Today
